Near-Elimination of Otitis Media Caused by 13-Valent Pneumococcal Conjugate Vaccine (PCV) Serotypes in Southern Israel Shortly After Sequential Introduction of 7-Valent/13-Valent PCV-Reference-Cited by-同舟云学术

Near-Elimination of Otitis Media Caused by 13-Valent Pneumococcal Conjugate Vaccine (PCV) Serotypes in Southern Israel Shortly After Sequential Introduction of 7-Valent/13-Valent PCV

Published:2014-08-25 Issue:12 Volume:59 Page:1724-1732
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Ben-Shimol Shalom,Givon-Lavi Noga,Leibovitz Eugene,Raiz Simon,Greenberg David,Dagan Ron

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference40 articles.

1. The burden of otitis media;Vaccine,2008

2. The occurrence of acute otitis media in infants. A life-table analysis;Int J Pediatr Otorhinolaryngol,1991

3. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media;Antimicrob Agents Chemother,1998

4. Distribution, dynamics and antibiotic resistance patterns of Streptococcus pneumoniae serotypes causing acute otitis media in children in southern Israel during the 10 year-period before the introduction of the 7-valent pneumococcal conjugate vaccine;Vaccine,2011

5. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children;Pediatr Infect Dis J,2000

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of Streptococcus pneumoniae isolates obtained from the middle ear fluid of US children, 2011–2021;Frontiers in Pediatrics;2024-07-15

2. Estimating geographical spread of Streptococcus pneumoniae within Israel using genomic data;Microbial Genomics;2024-06-24

3. Orbital complications of pediatric acute rhinosinusitis in the pneumococcal conjugate vaccine era;Pediatrics & Neonatology;2024-06

4. Otitis media: recent advances in otitis media vaccine development and model systems;Frontiers in Microbiology;2024-01-24

5. Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants;Vaccine;2024-01